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1. Introduction 
A deficiency of the plasma protein ct-l-antitrypsin 
causes apredisposition to lung disease. This is of 
particular importance to Northern Europeans some 
10% of whom are mixed heterozygotes for the 
normal (M) and a deficient (Z or S) allele [ 1 ]. These 
alleles have been shown to be due to single amino 
acid substitutions: in the mildly deficient S protein 
ofa glutamic acid by a valine [2] and in the severely 
deficient Z protein of a different glutamic acid by a 
lysine [3-5].  The Z defect is of particular interest as 
it apparently prevents secretion of the protein which 
consequently accumulates in the liver ceil. Two 
mechanisms have been suggested [6]. The molecular 
lesion could prevent cleavage of a secretory propeptide 
or it could disrupt an attachment si e of a carbohydrate 
side-chain essential for secretion. We report here 
further structural studies of the amino-terminus and 
mutation areas of the antitrypsin molecule, carried 
out to examine these proposals and alternative 
mechanisms that may be responsible for the deficiency 
associated with the Z and S variants. 
2. Methods 
ct-l-Antitrypsin was isolated from human plasma 
as in [2]. Sequence of the amino-terminal portion 
was determined using liquid phase Edman degrada- 
tion in an updated Beckman 890 B sequenator. PTH 
amino acids were identified by gas chromatography 
and by amino acid analysis of back-hydrolysed prod- 
ucts. The 'C' cyanogen bromide fragment was prepared 
and isolated by isoelectric focussing as in [31, with 
the exception that prior desialylation and denatura- 
tion of the antitrypsin was carried out by heating at 
80°C in 0.5 M H2SO4. Ampholines and urea were 
removed by gel fdtration on Sephadex G-50. 
Sequence determination f the C-fragment was 
carried out [2] using tryptic peptides and also peptides 
from digests with thermolysin, chymotrypsin or
Staphylococcus aureus V8 protease. Enzyme to sub- 
strate ratios of 1:30 were used with digestion at 
pH 8.6 in 0.05 M NH4HCO3 buffer. The peptides 
were eluted from paper peptide maps as in [2,5,7]. 
Electrophoresis was carried out at pH 6.5 with, as 
appropriate, subsequent electrophoresis at pH 2.1. 
Marker amino acids and grid plots were used [8] to 
determine peptide mobility and hence correlate 
molecular weight and charge. Ascending chromatog- 
raphy was carried out in the upper phase of isoamyl 
alcohol/pyridine/water (6:6:7). Amides were 
assigned from peptide and degradation-peptide 
mobilities. Overlaps were determined using chymo- 
tryptic digests and partial acid hydrolysates (0.5 M 
acetic acid, 14 h at 110°C) of the whole fragment. 
The molecular weight of the C-fragment was deter- 
mined by SDS-acrylamide gel electrophoresis. Glyco- 
peptides were identified by their characteristic 
chromatographic and electrophoretic mobilities. Full 
details of all the procedures used will be published 
[9,10]. 
Secondary structure of the C-fragment was pre- 
dicted using the computer program of A.D. McLachlan 
based on principles imilar to those in [11 ]. 
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Fig.1. Sequence data, human M ~-l-antitrypsin. Amino-terminal sequence by sequenator; cyanogen bromide C-fragment by peptide 
analysis with positions assigned by dansyl-Edman steps ( v) and enzyme specificity. T, trypsin;C, chymotrypsin; th, thermolysin; 
SA, S. aureus protease; HA, partial acid hydrolysis. The S and Z substitutions occur in the C-fragment: S, 22 Glu --* Val; Z, 100 
Glu ~ Lys. A carbohydrate side-chain is attached at Asn 5. 
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3. Results and discussion 
The sequence data is summarised in fig.1. The 
109 residue sequence of the C cyanogen bromide 
fragment is compatible with both the overall amino 
acid composition and the determined mol. wt 11 500 
and is in agreement with the sequence independently 
obtained by S. K. Chan (personal communication). 
As predicted [3], the C-fragment contains both the 
S and Z mutation sites. The positions of the S and Z 
substitutions atresidues 22 and 100, respectively, 
were placed from [2,5] and by independent mapping 
of the variants. The presence was confirmed of a 
carbohydrate linkage point at Asn 5 of the C-frag- 
ment, as in [ 12]. No other glycopeptide was detected. 
The computer prediction of secondary structure 
in the C-fragment showed the strongest features to be 
helical regions from Pro 13-His 27 and from 
Glu 81-Leu 96, and/~-sheets from Ala 6-Phe 11 and 
Leu 64-Phe 70. This places the point of attachment 
of the carbohydrate side chain as just prior to a/~-sheet 
region and strongly indicates that the S mutation 
(22 Glu ~ Val) has occurred on the hydrophilic face 
of an a-helical section. This last conclusion supports 
the proposal [2] that the observed lability of the 
S protein is due to the introduction of a hydrophobic 
residue on an external aspect of the molecule which 
would allow disadvantageous aggregation. 
Neither the S nor Z mutation is in a position that 
should directly affect attachment of the carbohydrate 
side-chain at residue 5. An alternative proposal for 
the inadequate secretion of the Z protein is that its 
mutation may be at the site of cleavage of a secretory 
propeptide [6] or prepropeptide. Any such uncleaved 
peptide would necessarily have to be small and 
situated at the amino-terminus since the Z protein has 
no detectable increase in molecular weight and has 
the same, single, amino-terminal residue (Glu) as the 
normal protein [9]. The Z mutation is at least 119 
residues from the amino-terminus which excludes the 
possibility that it is directly involved in the cleavage 
site of an amino-terminal peptide. These results, then, 
indicate that the S and Z mutations do not, at the 
primary sequence l vel, affect carbohydrate side-chain 
attachment oramino-terminal secretory peptide 
cleavage. Whether the conclusion is also true at the 
tertiary level will have to await crystallographic studies 
One possibility as to the defect in the Z protein is 
suggested from the primary sequence. This is the 
appearance in the Z variant of the sequence Asp-Lys-  
Lys (residue 99-101) analogous to the earlier Asp- 
Arg-Arg (residue 38-40). Double basic residues are 
known to act as a molecular marker for propeptide 
cleavage [13] but the explanation of the Z deficiency 
may lie in the wider role that is suspected for double 
basic residues, e.g., as markers for degradation 
cleavage [14]. 
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